Expanded Surveillance for Pediatric Infectious Diseases
🏛 Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)
✓ Free, no account · Source: Grants.gov · Last verified Jul 28, 2026
Can you apply?
This grant is for U.S. institutions conducting pediatric infectious disease surveillance. Public health agencies, hospitals, healthcare systems, and research institutions can apply. The network must conduct standardized surveillance of respiratory and gastroenteritis illnesses in children seeking healthcare. Component A (core surveillance in inpatient and emergency departments) is required. Optional components support outpatient surveillance and immune response studies.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- Jul 28, 2026 Applications open
- Dec 31, 2026 Application deadline in 155 days
- Jul 30, 2027 Award announced
- Sep 1, 2027 Project start
Program description
The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.
In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population.
Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity.
This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components.
Component A – Core Component (Required)
- Support inpatient and emergency department pediatric surveillance
- Follow the standardized protocol established by CDC
Optional Components
- Component B: Support outpatient pediatric surveillance
- Component C: Study immune response and infection
- Component D: Study immune response and immunization
Recipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the natural history of medically attended diseases.
Findings of this NOFO will:
- Improve best practices for diagnosis and treatment protocols
- Inform prevention product recommendations
- Guide public health strategies
- Reduce viral illness-associated hospitalizations and healthcare utilization among children
Who can apply
Eligible applicants
- 501(c)(3) Public Charity
- City / Municipal Government
- Community Health Center
- County Government
- Hospital
- Nonprofits
- Private University
- Public Authority
- Public K-12 School
- Public University
- Special District
- State Government
- Tribal Nation
- Tribal Organization
Demographic focus
How to apply
Application links
Key dates & requirements
Required documents
- CDC SF-424 (or equivalent federal form)
- Project Narrative
- Budget Narrative/Justification
- Statement of institutional commitment
- CDC Surveillance Protocol compliance document
- Letters of commitment from hospital partners
- Lab capability documentation
Program contact
- 👤 Jamal Bankhead
- 📧 JBankhead@cdc.gov
- 📞 404-718-4108
Funding track record
No recent recipient data available for CFDA 93.083 in our database.
This can happen for newer programs, programs that use non-standard award types (loans, direct payments, fellowships), or those funded through sub-agencies under different codes.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.083). How funding has trended year over year.
| 2024 | $23,100,096 | |
| 2025 | $15,407,781 | |
| 2026 est. | $15,350,000 |
FAQ
Who is eligible to apply?
U.S. public health agencies, hospitals, healthcare systems, and research institutions. Your institution must be able to conduct standardized pediatric surveillance following CDC protocols.
What must my institution do?
All applicants must support Component A surveillance in inpatient and ED settings. You may also propose optional components for outpatient surveillance or immune response studies.
What is the funding range?
Awards typically range from $850,000 to $1,140,000 annually. Total funding pool is $40 million.
Do I need cost sharing?
No cost sharing is required for this grant.
Can I reapply if rejected?
Yes, rejected applicants may reapply in future funding cycles.
💡 Tips for applicants
- Start planning early. CDC cooperative agreements require detailed protocols and institutional commitments. Secure leadership buy-in before applying.
- Review CDC's standardized surveillance protocol in detail. Your protocol must align exactly with their specifications.
- Focus on data quality and timeliness. Reviewers prioritize institutions with strong lab capacity and reliable patient enrollment processes.
- Consider which optional components strengthen your application. Component B (outpatient) is common; C and D require specialized capacity.
- Build relationships with CDC program officers. They can clarify expectations and help you address any protocol concerns.
⚠️ Common mistakes
Underestimating the operational burden of active surveillance. Many institutions lack lab capacity or adequate staffing to meet enrollment targets. Weak institutional commitment or unclear partnerships with hospital partners. Not aligning your methods exactly with CDC's standardized protocol requirements.
Similar grants
- OPEN Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network — Centers for Disease Control and Prevention - ERA
- OPEN Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge — Centers for Disease Control - NCBDDD
- OPEN RFA-SH-18-000 — Centers for Disease Control and Prevention - ERA
- OPEN Advancing Outbreak Detection, Notification, and Response Capacity by Implementing 7-1-7 in Partner Countries — Centers for Disease Control-GHC
- OPEN RFA-CE-18-000 — Centers for Disease Control and Prevention - ERA